Your browser doesn't support javascript.
loading
Enfortumab vedotin-induced cutaneous adverse events manifesting as miliaria-like eruptions with the presence of keratinocyte apoptosis in clinically intact skin.
Oya, K; Nakamura, Y; Iwamoto, K; Kimura, T; Negoro, H; Nishiyama, H; Fujisawa, Y.
  • Oya K; Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Nakamura Y; Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Iwamoto K; Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Kimura T; Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Negoro H; Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Nishiyama H; Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Fujisawa Y; Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
J Eur Acad Dermatol Venereol ; 36(12): e1009-e1011, 2022 12.
Article en En | MEDLINE | ID: mdl-35789043

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Miliaria / Anticuerpos Monoclonales Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Miliaria / Anticuerpos Monoclonales Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article